CODX vs PEP · rev $3.9M vs P/E 22, rev $93.92B
Co-Diagnostics, Inc. Common Stock (CODX) versus PepsiCo Inc (PEP) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
PepsiCo Inc (PEP) is a beverages - non-alcoholic company listed on NASDAQ. It is led by Ramon Laguarta.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported PEP revenue for 2025-12-27 was $93.92B. Net income was $8.24B. Revenue was up 2.3% from 2024-12-28 to 2025-12-27. PEP currently screens at market cap $193.55B and trailing P/E 22.2.
CODX currently screens at market cap $31.4M. PEP currently screens at market cap $193.55B and trailing P/E 22.2.
Not investment advice. Open the CODX and PEP stock pages for the full models.
Not investment advice.